State Ledger
Company profile

Larimar Therapeutics, Inc. CIK 1374690

Ticker
LRMR (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Bala Cynwyd, PA 19004
Fiscal year end
2025 (FY)
Market Data
Close
$2.16
Change
-$0.38
Change %
-14.82%
Volume
151,560

LRMR · trading date Oct 13, 2026 · previous close $2.53 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$165.67M
Total assets
$145.84M
Total liabilities
$67.76M
Stockholders' equity
$78.09M
Cash & equivalents
$85.41M
Operating income
-$172.50M
Operating cash flow
-$113.20M
Capital expenditures
$91.0K

Fiscal year 2025, via 10-K filed 2026-03-19. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$113.29M
Free cash flow margin
—
Liabilities / assets
46.5%
Equity / assets
53.5%
CapEx / revenue
—
Operating cash flow / net income
0.68×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$165.67M $145.84M $67.76M $78.09M
2024 — -$80.60M $200.23M $28.41M $171.81M
2023 — -$36.95M $95.94M $14.22M $81.72M
2022 — -$35.36M $126.41M $15.50M $110.90M
2021 — -$50.64M $78.67M $14.25M $64.41M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-04
Financials filed via
Form 10-K
filed 2026-03-19

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Bala Cynwyd, PA 19004
THREE BALA PLAZA EAST. SUITE 506
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:52 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Pennsylvania — Public Companies